Quintiles to study uterine fibroid drugs; Novartis mulls $1.8B CMO sale;

> The Patient-Centered Outcomes Research Institute awarded Quintiles ($Q) a research grant to study the effectiveness of treatments for uterine fibroids. More

> ClinTec is boosting its presence in Russia, expanding operations in Moscow, St. Petersburg and Novosibirsk. Story

> Novartis ($NVS) and billionaire Dietmar Hopp are considering selling off their contract manufacturing joint venture, LTS Lohmann, for up to $1.83 billion. Article

> Contract Pharmaceutical Services of Australia received an FDA warning letter, citing GMP violations at a pharmaceutical packaging facility. Item

> NextPharma won a contract to provide packaging services for a Mitsubishi Pharma kidney disease drug. Report